abstract |
The invention discloses 1302 novel acetylation sites peptides (including AQUA peptides) comprising an acetylation site of the invention, antibodies specifically bind to a novel acetylation site of the invention, and diagnostic and therapeutic uses of the above. The acetylation sites identified provide important information regarding metabolism in energy signaling pathways. |